Etanercept therapy in patients with autoimmunity and hepatitis C

M Khanna Department of Medicine and Clinical Research Center, UMDNJ‐Robert Wood Johnson Medical School, New Brunswick, NJ, USA

MA Shirodkar Department of Medicine and Clinical Research Center, UMDNJ‐Robert Wood Johnson Medical School, New Brunswick, NJ, USA

AB Gottlieb Department of Medicine and Clinical Research Center, UMDNJ‐Robert Wood Johnson Medical School, New Brunswick, NJ, USACorrespondence[email protected]

Abstract

Accumulated data suggest that etanercept may be a therapeutic option in patients with hepatitis C and coexisting autoimmune disorders such as rheumatoid arthritis, psoriasis, psoriatic arthritis and ankylosing spondylitis. Additionally, etanercept may actually be of benefit, when used in combination with standard treatments, for hepatitis C.

Keywords

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Etanercept therapy in patients with autoimmunity and hepatitis C

Information for

Open access

Opportunities

Help and information

Etanercept therapy in patients with autoimmunity and hepatitis C

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature